DARPA BRICS Synthetic Biology Proposers’ Conference

The development of increasingly sophisticated techniques and tools to sequence, synthesize and manipulate genetic material has led to the rapidly maturing discipline of synthetic biology.

To date, work in synthetic biology has focused primarily on manipulating individual species of domesticated organisms to perform specific tasks, such as producing medicines or fuels.

These species tend to be both relatively fragile (requiring precise environmental conditions to survive) and relatively unstable (subject to losing their engineered advantages through genetic attrition or recombination). The costs of maintaining required environmental controls and detecting and compensating for genetic alterations are substantial and severely limit the widespread application of synthetic biology to U.S. national security missions.

To help address these challenges, DARPA has created the Biological Robustness in Complex Settings (BRICS) program. BRICS seeks to develop the fundamental understanding and component technologies needed to increase the biological robustness and stability of engineered organisms while maintaining or enhancing the safe application of those organisms in complex biological environments. The goal is to create the technical foundation for future engineered biological systems to achieve greater biomedical, industrial and strategic potential.

“By making these systems more robust, stable and safe, BRICS seeks to harness the full range of capabilities at the intersection of engineering and biology,” said Justin Gallivan, DARPA program manager. “These capabilities could include efficient on-demand bio-production of novel drugs, fuels, sensors and coatings; or engineered microbes able to optimize human health by treating or preventing disease.”

To familiarize potential participants with the technical objectives of BRICS, DARPA has scheduled a Proposers’ Day on Thursday, August 21, 2014, at the Capital Conference Center in Arlington, VA.

The goals of the Proposers’ Day are:

  • To introduce the science and technology community (industry, academia, and government) to the BRICS program vision and goals;
  • To facilitate interaction between investigators that may have capabilities to develop elements of interest and relevance to the BRICS goals; and
  • To encourage and promote teaming arrangements among organizations that have the relevant expertise, research facilities and capabilities for executing research and development responsive to the BRICS program goals.

The event will include overview presentations by government personnel and provide opportunities for team building among the participants.

Advance registration is required prior to August 18, 2014. The full Broad Agency Announcement for BRICS is expected to be released prior to the Proposers’ Day. (Editor’s Update: The BRICS BAA was released August 12, 2014.)

A key goal of the program is to understand the dynamics that influence stability, robustness and safety in complex biological environments. Once the components and interactions comprising those dynamics are adequately understood, DARPA intends to support an integration team that would use the developed methods and tools to build a contained multi-species system that embodies all the attributes required to operate in a complex setting at scale.

While the technologies that BRICS aims to help develop could find eventual application in non-laboratory settings—including, for example, the human gastrointestinal tract or complex mechanical or chemical environments where biologically based sensors or films might be useful—all work performed in this program will occur in controlled laboratory settings.

Proposals that include efforts to manipulate or study genetically modified organisms in open ecosystems or in any context not completely insulated from the natural environment will not be considered. Proposers must ensure and demonstrate throughout the program that all methods and demonstrations of capability comply with all applicable federal, state, and local regulations for manipulation of genes and organisms and follow all guidance for biological safety and biosecurity.

Sources: DARPA press release, FBO.gov solicitation. Image courtesy of DARPA.

Quantitative Viral Outgrowth Assay

NIAID Creating Quantitative Viral Outgrowth Assay Service

MAPP Biopharmaceutical Awarded Funding for Ebola Drug